{"product_id":"retirzepatide-35mg-retatrutide-tirzepatide","title":"Retirzepatide 35mg Retatrutide + Tirzepatide","description":"\u003cp class=\"PDq2pG_selectionAnchorContainer\"\u003e\u003cstrong\u003eRetirzepatide is a research blend containing 20mg retatrutide and 15mg tirzepatide.\u003c\/strong\u003e Retatrutide is an investigational triple-receptor agonist targeting GIP, GLP-1 and glucagon receptors, while tirzepatide is a GIP\/GLP-1 receptor agonist. Both compounds are being studied in metabolic and obesity-related research. \u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eResearch areas include:\u003c\/strong\u003e metabolic research, glucose and insulin signalling, body-weight regulation, appetite-related pathways and cardiometabolic health. Clinical studies have evaluated retatrutide and tirzepatide separately, but the \u003cstrong\u003especific 20mg retatrutide + 15mg tirzepatide combination shown here has not been established as an approved or clinically validated combination treatment\u003c\/strong\u003e. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImportant:\u003c\/strong\u003e Retatrutide remains investigational and is \u003cstrong\u003enot approved for general human use\u003c\/strong\u003e. The specific Retirzepatide blend and self-mix formulation shown here should not be represented as an approved treatment. This product is provided for \u003cstrong\u003eresearch purposes only\u003c\/strong\u003e and is not intended to diagnose, treat, cure or prevent any disease or medical condition.\u003c\/p\u003e","brand":"Xenolabs","offers":[{"title":"Default Title","offer_id":43616029442096,"sku":null,"price":0.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0704\/9389\/6752\/files\/RetirzepatideSelfMixVials.jpg?v=1789405066","url":"https:\/\/xeno-labs.co.za\/products\/retirzepatide-35mg-retatrutide-tirzepatide","provider":"Xenolabs","version":"1.0","type":"link"}